• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Substance Use Disorder Treatment Providers' Knowledge and Opinions Toward Testing and Treatment of Chronic Hepatitis C in Rural North Carolina.北卡罗来纳州农村地区物质使用障碍治疗提供者对慢性丙型肝炎检测与治疗的知识及看法
Rural Ment Health. 2022 Jul;46(3):162-173. doi: 10.1037/rmh0000200. Epub 2022 Feb 3.
2
Mitigating the Risk of Infectious Diseases Among Rural Drug Users in Western North Carolina: Results of the Southern Appalachia Test, Link, Care (SA-TLC) Health Care Provider Survey.北卡罗来纳州西部农村吸毒者传染性疾病风险的缓解:南方阿巴拉契亚测试、链接、关怀(SA-TLC)医疗保健提供者调查的结果。
J Rural Health. 2020 Mar;36(2):208-216. doi: 10.1111/jrh.12409. Epub 2019 Nov 19.
3
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).注射吸毒人群丙型肝炎病毒感染的综合治疗:一项随机对照试验的研究方案(INTRO-HCV)。
BMC Infect Dis. 2019 Nov 8;19(1):943. doi: 10.1186/s12879-019-4598-7.
4
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.35 个欧洲国家的民间社会对与世界卫生组织 2030 年消除目标相关的丙型肝炎应对措施的监测。
Harm Reduct J. 2020 Nov 19;17(1):89. doi: 10.1186/s12954-020-00439-3.
5
Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review.注射吸毒且携带丙型肝炎病毒人群的综合关怀模式:系统评价。
Int J Drug Policy. 2019 Oct;72:146-159. doi: 10.1016/j.drugpo.2019.05.023. Epub 2019 May 27.
6
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.《通过治疗提高丙型肝炎认识(HepCATT)研究:改善英格兰丙型肝炎病毒感染的注射吸毒者的护理衔接》。
Addiction. 2019 Jun;114(6):1113-1122. doi: 10.1111/add.14569. Epub 2019 Mar 12.
7
MHepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.MHepPrEP:一项多地点多环境随机对照试验的研究方案,针对的是注射吸毒者的整合 HIV 预防和 HCV 护理。
Trials. 2022 Apr 23;23(1):341. doi: 10.1186/s13063-022-06085-3.
8
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States.美国临床医生在治疗丙型肝炎病毒和物质使用障碍患者时面临的障碍、认知及实践情况。
Prev Med Rep. 2023 Feb 13;32:102138. doi: 10.1016/j.pmedr.2023.102138. eCollection 2023 Apr.
9
'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.“全面治疗我这个人,而不仅仅是我的病情”:注射吸毒者的丙型肝炎护理提供偏好的定性探索。
Addict Sci Clin Pract. 2021 Aug 12;16(1):52. doi: 10.1186/s13722-021-00260-8.
10
Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018.2016-2018 年,新墨西哥州农村地区注射吸毒的年轻人中,同时存在心理健康问题与丙型肝炎感染状况的关联性。
Addict Sci Clin Pract. 2022 Oct 20;17(1):58. doi: 10.1186/s13722-022-00340-3.

引用本文的文献

1
Prescribing direct-acting antivirals for hepatitis C treatment: a scoping review of factors that influence primary care providers.开具用于丙型肝炎治疗的直接抗病毒药物:对影响初级保健提供者的因素的范围综述
BMC Prim Care. 2025 May 13;26(1):157. doi: 10.1186/s12875-025-02865-3.

本文引用的文献

1
Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era.口服直接抗病毒药物时代注射吸毒者的丙型肝炎治疗情况
Liver Int. 2020 Oct;40(10):2407-2416. doi: 10.1111/liv.14634.
2
Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017.密歇根州的阿片类药物处方与阿片类药物过量死亡情况:城乡比较及2013 - 2017年的变化
Addict Behav Rep. 2019 Nov 15;11:100234. doi: 10.1016/j.abrep.2019.100234. eCollection 2020 Jun.
3
Notes from the Field: Outbreak of Human Immunodeficiency Virus Infection Among Persons Who Inject Drugs - Cabell County, West Virginia, 2018-2019.现场记录:西弗吉尼亚州卡贝尔县2018 - 2019年注射吸毒者中人类免疫缺陷病毒感染暴发
MMWR Morb Mortal Wkly Rep. 2020 Apr 24;69(16):499-500. doi: 10.15585/mmwr.mm6916a2.
4
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新:美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
5
Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience.参与丙型肝炎管理和直接作用抗病毒药物治疗的障碍和促进因素:全科医生和毒品与酒精专家的实践经验。
Drug Alcohol Depend. 2020 Jan 1;206:107705. doi: 10.1016/j.drugalcdep.2019.107705. Epub 2019 Nov 2.
6
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.随机实用临床试验的基本原理和设计,用于为注射毒品的丙型肝炎患者提供以患者为中心的治疗模式:HERO 研究。
Contemp Clin Trials. 2019 Dec;87:105859. doi: 10.1016/j.cct.2019.105859. Epub 2019 Oct 24.
7
The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases.阿巴拉契亚农村地区的阿片类药物和相关药物流行:受影响人群、风险因素和传染病的系统评价。
Subst Abus. 2020;41(1):35-69. doi: 10.1080/08897077.2019.1635555. Epub 2019 Aug 12.
8
Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.消除吸毒人群中的丙型肝炎病毒感染:确保所有人都能公平地获得预防、治疗和护理。
Int J Drug Policy. 2019 Oct;72:1-10. doi: 10.1016/j.drugpo.2019.07.016. Epub 2019 Jul 23.
9
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study.伊朗德黑兰一项提高吸毒人群 HCV 检测、与医护机构联系和治疗的干预措施:ENHANCE 研究。
Int J Drug Policy. 2019 Oct;72:99-105. doi: 10.1016/j.drugpo.2019.07.002. Epub 2019 Jul 11.
10
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study.阿片类药物激动剂治疗医师对丙型肝炎病毒感染检测、管理和治疗相关认知障碍:C-SCOPE 研究。
J Viral Hepat. 2019 Sep;26(9):1094-1104. doi: 10.1111/jvh.13119. Epub 2019 Jun 11.

北卡罗来纳州农村地区物质使用障碍治疗提供者对慢性丙型肝炎检测与治疗的知识及看法

Substance Use Disorder Treatment Providers' Knowledge and Opinions Toward Testing and Treatment of Chronic Hepatitis C in Rural North Carolina.

作者信息

Evon Donna M, Hurt Christopher B, Carpenter Delesha M, Rhea Sarah K, Hennessy Caitlin M, Zule William A

机构信息

Division of Gastroenterology & Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Rural Ment Health. 2022 Jul;46(3):162-173. doi: 10.1037/rmh0000200. Epub 2022 Feb 3.

DOI:10.1037/rmh0000200
PMID:35967261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9371459/
Abstract

Poor access to care has made western North Carolina vulnerable to an outbreak of hepatitis C viral infection (HCV), particularly among persons who inject drugs (PWID). As substance use disorder (SUD) treatment providers could potentially improve linkage to HCV testing and treatment, we sought to understand SUD providers, clinic and client characteristics; referral patterns; HCV knowledge; willingness to participate in additional trainings; and local linkage-to-care pathways for treatment of substance use and HCV. Online survey data were collected from 78 SUD providers serving PWID in eight western rural North Carolina counties. Providers' attitudes toward working with HCV+ clients were very positive. One-third of providers reported a low fund of knowledge regarding HCV, HCV treatment, and financial assistance opportunities. Non-prescribing providers rarely initiated discussions about HCV testing/treatment, but were receptive to training. Respondents indicated that HCV testing and treatment were best delivered at local health departments or primary care clinics but were open to other venues where PWID access care. The vast majority of prescribing and non-prescribing providers expressed interest in obtaining training in HCV treatments, how to obtain HCV medications and topics on advanced liver disease. Data from prescribing and non-prescribing SUD providers suggest opportunities to develop or expand integrated care models for HCV testing/treatment in PWID in rural Appalachian North Carolina.

摘要

医疗服务获取不便使得北卡罗来纳州西部容易爆发丙型肝炎病毒感染(HCV),尤其是在注射吸毒者(PWID)中。由于物质使用障碍(SUD)治疗提供者可能会改善与HCV检测和治疗的联系,我们试图了解SUD提供者、诊所和客户的特征;转诊模式;HCV知识;参与额外培训的意愿;以及当地针对物质使用和HCV治疗的护理联系途径。我们从北卡罗来纳州西部八个农村县为PWID提供服务的78名SUD提供者那里收集了在线调查数据。提供者对与HCV阳性客户合作的态度非常积极。三分之一的提供者报告称对HCV、HCV治疗和经济援助机会的了解有限。不开具处方的提供者很少主动讨论HCV检测/治疗,但愿意接受培训。受访者表示,HCV检测和治疗最好在当地卫生部门或初级保健诊所进行,但也对PWID能够获得护理的其他场所持开放态度。绝大多数开具处方和不开具处方的提供者都表示有兴趣接受HCV治疗、如何获取HCV药物以及晚期肝病相关主题的培训。开具处方和不开具处方的SUD提供者的数据表明,有机会在北卡罗来纳州阿巴拉契亚农村地区为PWID开发或扩大HCV检测/治疗的综合护理模式。